a public good project by the
Synthesis
Company
of California

© 2026

Ramón Corbalán | doi.page

0 works0 citations0 h-index

Ramón Corbalán

Pontificia Universidad Católica de Chile(CL)

Publications by Year

Research Areas

Cardiovascular Function and Risk Factors, Antiplatelet Therapy and Cardiovascular Diseases, Heart Failure Treatment and Management, Acute Myocardial Infarction Research, Atrial Fibrillation Management and Outcomes

Most-Cited Works

→ The TIMI Risk Score for Unstable Angina/Non–ST Elevation MI(2000)3,222 cited
→ Prasugrel versus Clopidogrel for Acute Coronary Syndromes without Revascularization(2012)865 cited
→ Greater Clinical Benefit of More Intensive Oral Antiplatelet Therapy With Prasugrel in Patients With Diabetes Mellitus in the Trial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet Inhibition With Prasugrel–Thrombolysis in Myocardial Infarction 38(2008)756 cited
→ Cardiac Myosin Activation with Omecamtiv Mecarbil in Systolic Heart Failure(2020)627 cited
→ Ticagrelor for Prevention of Ischemic Events After Myocardial Infarction in Patients With Peripheral Artery Disease(2016)385 cited
→ Psychologic Stress and Threshold for Repetitive Ventricular Response(1973)224 cited

→ Efficacy and safety of ticagrelor for long-term secondary prevention of atherothrombotic events in relation to renal function: insights from the PEGASUS-TIMI 54 trial(2015)

82 cited

→ Enoxaparin is superior to unfractionated heparin in patients with ST elevation myocardial infarction undergoing fibrinolysis regardless of the choice of lytic: an ExTRACT-TIMI 25 analysis(2007)75 cited

→ Association of diabetes mellitus and glycemic control strategies with clinical outcomes after acute coronary syndromes(2004)74 cited

→ Attained Educational Level and Incident Atherothrombotic Events in Low- and Middle-Income Compared With High-Income Countries(2010)65 cited